RE:RE:RE:New job posting Again, if preclinical wasn't sound, you would scrap the program and go back to the drawing board. To me, this reads as if there was lack of governance relating to the trial. Whether that be lack of proper protocols or poor communication or both, who knows. But this does indicate they want to move something forward.
SPCEO1 wrote: That reads to me like an indictment of Christian. Perhaps on further review, the great preclinical work may have had some flaws? Or, it could be they found protocols were not being followed in the phase 1a and 1b leading to the pause due to weird results. There clearly is a big gap between the preclinical results and the still unknown phase 1a and 1b results, so I am sure they are trying to figure that out.
scarlet1967 wrote: "Audit activities to ensure that Theratechnologies pre-clinical and clinical studies are conducted according to protocols and that any deviation is documented and assessed"
THTX isn't involved with any preclinical studies but Sort1!!